104 related articles for article (PubMed ID: 22031589)
1. Loss of RKIP expression during the carcinogenic evolution of endometrial cancer.
Martinho O; Faloppa CC; Neto CS; Longatto-Filho A; Baiocchi G; da Cunha IW; Soares FA; Fregnani JH; Reis RM
J Clin Pathol; 2012 Feb; 65(2):122-8. PubMed ID: 22031589
[TBL] [Abstract][Full Text] [Related]
2. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
Chatterjee D; Sabo E; Tavares R; Resnick MB
Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
4. Absence of RKIP expression is an independent prognostic biomarker for gastric cancer patients.
Martinho O; Simões K; Longatto-Filho A; Jacob CE; Zilberstein B; Bresciani C; Gama-Rodrigues J; Cecconello I; Alves V; Reis RM
Oncol Rep; 2013 Feb; 29(2):690-6. PubMed ID: 23232914
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker.
Moon A; Park JY; Sung JY; Park YK; Kim YW
Pathology; 2012 Oct; 44(6):534-9. PubMed ID: 22935977
[TBL] [Abstract][Full Text] [Related]
6. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
[TBL] [Abstract][Full Text] [Related]
7. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
[TBL] [Abstract][Full Text] [Related]
8. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.
Hagan S; Al-Mulla F; Mallon E; Oien K; Ferrier R; Gusterson B; García JJ; Kolch W
Clin Cancer Res; 2005 Oct; 11(20):7392-7. PubMed ID: 16243812
[TBL] [Abstract][Full Text] [Related]
9. BAG-1 expression in normal endometrium, endometrial hyperplasia and endometrial cancer.
Song JY; Kim JW; Lee JK; Lee NW; Yeom BW; Kim SH; Lee KW
Acta Obstet Gynecol Scand; 2008; 87(8):862-7. PubMed ID: 18704778
[TBL] [Abstract][Full Text] [Related]
10. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.
Fu Z; Kitagawa Y; Shen R; Shah R; Mehra R; Rhodes D; Keller PJ; Mizokami A; Dunn R; Chinnaiyan AM; Yao Z; Keller ET
Prostate; 2006 Feb; 66(3):248-56. PubMed ID: 16175585
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer.
Taponeco F; Curcio C; Giuntini A; Nardini V; Fornaciari G; Artini PG; D'Ambrogio G; Genazzani AR
J Exp Clin Cancer Res; 2001 Jun; 20(2):239-46. PubMed ID: 11484981
[TBL] [Abstract][Full Text] [Related]
12. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL
Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093
[TBL] [Abstract][Full Text] [Related]
13. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
Segawa T; Sasagawa T; Saijoh K; Inoue M
Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
[TBL] [Abstract][Full Text] [Related]
15. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.
Castellvi J; Garcia A; Ruiz-Marcellan C; Hernández-Losa J; Peg V; Salcedo M; Gil-Moreno A; Ramon y Cajal S
Hum Pathol; 2009 Oct; 40(10):1418-26. PubMed ID: 19428047
[TBL] [Abstract][Full Text] [Related]
16. Leukaemia inhibitory factor (LIF) is immunohistochemically expressed in normal, hyperplastic and malignant endometrial tissue.
Mylonas I; Makovitzky J; Shabani N; Richter DU; Kuhn C; Jeschke U; Briese V; Friese K
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):101-8. PubMed ID: 15596282
[TBL] [Abstract][Full Text] [Related]
17. Reduced Raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis.
Kim HS; Park SJ; Lee KY; Park YK; Kim YW
Oncol Rep; 2012 Jul; 28(1):161-71. PubMed ID: 22562283
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas.
Allard JE; Risinger JI; Morrison C; Young G; Rose GS; Fowler J; Berchuck A; Maxwell GL
Gynecol Oncol; 2007 Oct; 107(1):52-7. PubMed ID: 17582475
[TBL] [Abstract][Full Text] [Related]
19. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
20. Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis.
Giatromanolaki A; Sivridis E; Gatter KC; Turley H; Harris AL; Koukourakis MI;
Gynecol Oncol; 2006 Dec; 103(3):912-8. PubMed ID: 16837029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
